Literature DB >> 20361370

[Indications and principles of metabolic surgery].

R A Weiner1.   

Abstract

Bariatric surgery is known to be the most effective and long lasting treatment for morbid obesity and many related conditions, but now mounting evidence suggests it may be among the most effective forms of treatment for metabolic diseases and conditions including type 2 diabetes, hypertension, high cholesterol levels, non-alcoholic fatty liver disease and obstructive sleep apnea. Surgery for severe obesity goes way beyond weight loss. This surgery results in the complete remission or significant improvement of type 2 diabetes and other life-threatening diseases in most patients. The new name metabolic surgery was created and reflects this expanded and evolving view of surgery. Therefore, metabolic surgery is expected to play an ever increasing role in managing these diseases. New research results indicate that metabolic surgery may improve insulin resistance and secretion by mechanisms independent of weight loss, most likely involving changes in gastrointestinal hormones. Many patients with type 2 diabetes experience complete remission within days of metabolic surgery, long before significant weight is lost. This has led to a new concept that metabolic surgery may also be appropriate for diabetic individuals who are of normal weight or only slightly overweight.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20361370     DOI: 10.1007/s00104-009-1859-9

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  34 in total

1.  Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.

Authors:  Carlos K Furuya; Claudia P M S de Oliveira; Evandro S de Mello; Joel Faintuch; Alessandra Raskovski; Mitsunori Matsuda; Denise C P Vezozzo; Alfredo Halpern; Arthur B Garrido; Venâncio A F Alves; Flair J Carrilho
Journal:  J Gastroenterol Hepatol       Date:  2007-04       Impact factor: 4.029

2.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Francesco Rubino; Jacques Marescaux
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

3.  How do we define cure of diabetes?

Authors:  John B Buse; Sonia Caprio; William T Cefalu; Antonio Ceriello; Stefano Del Prato; Silvio E Inzucchi; Sue McLaughlin; Gordon L Phillips; R Paul Robertson; Francesco Rubino; Richard Kahn; M Sue Kirkman
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

4.  Improvement in glycemic control in morbidly obese type 2 diabetic subjects by gastric stimulation.

Authors:  Arthur Bohdjalian; Gerhard Prager; Christoph Rosak; Rudolf Weiner; Ralf Jung; Markus Schramm; Ricardo Aviv; Karin Schindler; Walid Haddad; Norbert Rosenthal; Bernhard Ludvik
Journal:  Obes Surg       Date:  2009-07-03       Impact factor: 4.129

5.  Duodenal switch: long-term results.

Authors:  Picard Marceau; Simon Biron; Frédéric-Simon Hould; Stéfane Lebel; Simon Marceau; Odette Lescelleur; Laurent Biertho; Serge Simard
Journal:  Obes Surg       Date:  2007-11       Impact factor: 4.129

6.  Incidence of diabetes in youth in the United States.

Authors:  Dana Dabelea; Ronny A Bell; Ralph B D'Agostino; Giuseppina Imperatore; Judith M Johansen; Barbara Linder; Lenna L Liu; Beth Loots; Santica Marcovina; Elizabeth J Mayer-Davis; David J Pettitt; Beth Waitzfelder
Journal:  JAMA       Date:  2007-06-27       Impact factor: 56.272

7.  Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1.

Authors:  Tian Tian Wang; San Yuan Hu; Hai Dong Gao; Guang Yong Zhang; Chong Zhong Liu; Jin Bo Feng; Eldo E Frezza
Journal:  Ann Surg       Date:  2008-06       Impact factor: 12.969

8.  Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion.

Authors:  Manish Parikh; Patricia Ayoung-Chee; Eleny Romanos; Nichole Lewis; H Leon Pachter; George Fielding; Christine Ren
Journal:  J Am Coll Surg       Date:  2007-09-18       Impact factor: 6.113

9.  Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device.

Authors:  M Camilleri; J Toouli; M F Herrera; B Kulseng; L Kow; J P Pantoja; R Marvik; G Johnsen; C J Billington; F G Moody; M B Knudson; K S Tweden; M Vollmer; R R Wilson; M Anvari
Journal:  Surgery       Date:  2008-05-09       Impact factor: 3.982

10.  Resolution of nonalcoholic steatohepatits after gastric bypass surgery.

Authors:  Xiuli Liu; Audrey J Lazenby; Ronald H Clements; Nirag Jhala; Gary A Abrams
Journal:  Obes Surg       Date:  2007-04       Impact factor: 4.129

View more
  5 in total

Review 1.  [Metabolic surgery or conservative measures as therapy of obese type 2 diabetics?]

Authors:  Udo Jahn; Thomas Schubert; Sibylle Schlepp; Heinz Jürgen Deuber
Journal:  Wien Med Wochenschr       Date:  2016-12-05

2.  Comparison Between Banded and Nonbanded Roux-En-Y Gastric Bypass with 2-Year Follow-Up: a Preliminary Retrospective Analysis.

Authors:  Mohit Bhandari; Shilpa Bhandari; Arun Mishra; Winni Mathur; Atul Dixit
Journal:  Obes Surg       Date:  2016-01       Impact factor: 4.129

Review 3.  [Concept of reconstructive body shaping in obesity. Evidence-based therapy algorithm].

Authors:  A Dragu; R E Horch
Journal:  Chirurg       Date:  2014-01       Impact factor: 0.955

4.  Portal Vein Thrombosis due to Prothrombin Gene Mutation following Sleeve Gastrectomy.

Authors:  Murad Baba; Jordan Fakhoury; Amer Syed
Journal:  Case Rep Gastrointest Med       Date:  2015-11-10

5.  Outcomes of a Presurgical Optimization Program for Elective Hernia Repairs Among High-risk Patients.

Authors:  Lia D Delaney; Ryan Howard; Krisinda Palazzolo; Anne P Ehlers; Shawna Smith; Michael Englesbe; Justin B Dimick; Dana A Telem
Journal:  JAMA Netw Open       Date:  2021-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.